Based on this mechanism, it is believed that IL-18 and IP-10/CXCL10 do not exert tumor-suppressive effects, but rather, promote IFN-γ secretion and chemoattraction of CXCR3+ cells into the NPC TME. The gene discussed is CXCR3; the disease is nasopharyngeal carcinoma.